Meeting Banner
Abstract #1834

Comparison of detection rate of prostate cancer between mpMRI guided in-bore biopsy and routine TRUS biopsy

Sujeet K Mewar1, Sanjay Sharma2, Ekta Dhamijia 3, Sanjay Thulkar3, Sridhar Panaiyadiyan4, Pradeep Kumar1, S. Senthil Kumaran1, Virendra Kumar1, S. Datta Gupta5, Rajeev Kumar4, and Naranamangalam R Jagannathan1

1Department of NMR and MRI Facility, All India Institute of Medical Sciences, New Delhi, India, 2Department of Radio-diagnosis, All India Institute of Medical Sciences, New Delhi, India, 3Department of Radio-diagnosis, IRCH, All India Institute of Medical Sciences, New Delhi, India, 4Department of Urology, All India Institute of Medical Sciences, New Delhi, India, 5Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

The present study demonstrated the role of mpMRI guided in-bore biopsy for detection of prostate cancer (PCa). Patients were recruited based on PSA > 4 ng/ml and abnormal DRE. The PCa detection rate between the two groups of patients, namely 25 patients (Group I) who underwent in-bore biopsy and 73 patients (Group II) who underwent TRUS biopsy were compared. The PCa detection rate of in-bore targeted biopsy was 52% compared to 34.3% for TRUS biopsy. Our data also indicated that in-bore MR targeted biopsy significantly increased the detection rate of PCa when compared with the standard 12 core TRUS biopsy.

This abstract and the presentation materials are available to members only; a login is required.

Join Here